menu
    • menu

    Company profile for Matinas BioPharma

    NEW Drugs in Dev: 7
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Veranova: A CDMO that manages complexity with confidence.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Matinas BioPharma is a clinical-stage biopharmaceutical company focused on development of its lead product candidate, MAT9001, for the treatment of cardiovascular and metabolic conditions. MAT9001 is a prescription-only omega-3 fatty acid-based composition, comprised primarily of EPA and DPA, under development for hypertriglyceridemia, that was specifically designed to overcome the shortcomings seen from other agents in the om...
    Matinas BioPharma is a clinical-stage biopharmaceutical company focused on development of its lead product candidate, MAT9001, for the treatment of cardiovascular and metabolic conditions. MAT9001 is a prescription-only omega-3 fatty acid-based composition, comprised primarily of EPA and DPA, under development for hypertriglyceridemia, that was specifically designed to overcome the shortcomings seen from other agents in the omega-3 class. Company leadership has a deep history and knowledge of cardiovascular drug development and is supported by a world-class team of scientific advisors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Matinas BioPharmaUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1545 Route 206, Suite 302 Bedminster, New Jersey 07921
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.matinasbiopharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/matinas-biopharma
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/MatinasBio

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AACR Annual meeting

    AACR Annual meeting

    Not Confirmed

    envelop Contact Supplier

    AACR Annual meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Matinas Biopharma Not Compliant With NYSE American Listing
    Matinas Biopharma Not Compliant With NYSE American Listing

    03 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/03/3268148/32419/en/Matinas-BioPharma-Receives-Notice-of-Non-Compliance-with-NYSE-American-Continued-Listing-Standards.html

    GLOBENEWSWIRE
    03 Apr 2026
    Share Share
    Matinas BioPharma Appoints Biotech Leaders to Board
    Matinas BioPharma Appoints Biotech Leaders to Board

    11 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/11/3040409/32419/en/Matinas-BioPharma-Appoints-Seasoned-Biotech-Leaders-to-Board-of-Directors.html

    GLOBENEWSWIRE
    11 Mar 2025
    Share Share
    Matinas Bio Acquires Preferred Stock, Dr. Robin Joins Board
    Matinas Bio Acquires Preferred Stock, Dr. Robin Joins Board

    13 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/13/3026339/32419/en/Matinas-BioPharma-Announces-Agreement-for-the-Acquisition-of-Preferred-Stock-and-Appointment-of-Dr-Robin-L-Smith-to-the-Board-of-Directors.html

    GLOBENEWSWIRE
    13 Feb 2025
    Share Share
    Matinas BioPharma Appoints Evelyn to BoD as Audit Committee Chair
    Matinas BioPharma Appoints Evelyn to BoD as Audit Committee Chair

    07 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/07/3022725/32419/en/Matinas-BioPharma-Appoints-Evelyn-D-An-to-Board-of-Directors-as-Audit-Committee-Chair.html

    GLOBENEWSWIRE
    07 Feb 2025
    Share Share
    Matinas BioPharma Receives NYSE Noncompliance Notice
    Matinas BioPharma Receives NYSE Noncompliance Notice

    10 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/10/3007959/32419/en/Matinas-BioPharma-Receives-NYSE-Noncompliance-Notice.html

    GLOBENEWSWIRE
    10 Jan 2025
    Share Share
    Matinas BioPharma Terminates MAT2203 Partnership, Cuts Workforce
    Matinas BioPharma Terminates MAT2203 Partnership, Cuts Workforce

    31 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/31/2972421/32419/en/Matinas-BioPharma-Announces-the-Termination-of-MAT2203-Partnership-Negotiations-and-Implements-Immediate-Workforce-Reduction.html

    GLOBENEWSWIRE
    31 Oct 2024
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search